Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Flair who wrote (1775)	4/29/1998 1:53:00 PM
From: taylorfife	Read Replies (1) \| Respond to of 9523

I thought that the insurance companies were limiting the number of pills per month that they would pay for, not the number of times a patient can take the pill per month as reported in the FOOL.

To: Flair who wrote (1775)	4/29/1998 1:59:00 PM
From: Dr. Seuss	Respond to of 9523

<<<note from their doctor stating that they suffer from erectile dysfunction and limiting the number of pills a patient can take per month. >>> Dear Comlumbia/HCA, Johnny really needs to get him some, so please let him take Viagra. I understand it is your policy to only allow 15 boingee's a month, but given the age of his wife and length of time since they last winky-winkied, I would recommend a total of 25 pills as they both can handle it. Thank you very much, we appreciate your meddling in patient affairs and violating their right to privacy and confidentiality. dr.seuss@HMO.MCARE.MUST.GO/screw.the.health.insurance.companies

To: Flair who wrote (1775)	4/30/1998 4:47:00 PM
From: Ibexx	Read Replies (3) \| Respond to of 9523

Flair and all, CS First Boston downgraded PFE today from BUY to HOLD on valuation basis. Interestingly, it also UPGRADED Eastman Kodak which had been on a declining stream of EPS for some time, and is currently selling at a lofty P/E of 275 (cf, Yahoo.com). Does that tell you something about the brokerage houses' valuation logic? Regards, Ibexx PS: the stock rose anyway.